Septin9 is the new FDA approved non-invasive screening test for the detection of colon cancer. Protect your health by a preventive screening with just a single blood sample.
- Colorectal cancer is the second most common cause of cancer-related deaths.
- More than 230,000 people in Europe die of this disease every year.
- Colorectal cancer is curable if diagnosed early.
Who Should Be Tested and When
- Individuals with an average risk of colon cancer, that do not show any symptoms.
- Preventive screening for CRC is recommended for individuals above 50 year, but younger patients can do the test as well.
The Septin9 test is a safe and non-invasive alternative for the early detection of colorectal cancer.
It will not replace a colonoscopy but can be seen as a comfortable endorsement for patients, who are opposed to invasive screening methods.
Results and Interpretation
Test results are interpreted as follows:
- Patients tested negative, do not show an increased likelihood for the presence of CRC (specificity of the test: 99%). We therefore recommend performing an annual preventive screening with the Septin9 test.
- A positive test result means that the likelihood of the patient having colorectal cancer is increased. Since 45.7% of the patients tested positive are truly positive (positive predictive value), a colonoscopy is strongly recommended for a final diagnosis.
The Septin9 blood test can be performed at any time and can easily be included in a general health check-up. No dietary restrictions are required before performing the test.
Please book in for a consultation with a Doctor at our clinic if you feel you might require screening.